Global /China /Healthcare /Medical Care Facilities /SCAL

Stem Cell Authority, Ltd.

SCAL

• OTCMKTS: SCAL • Delayed

0.0002USD 0%

As of 6 June 2026, Stem Cell Authority, Ltd. has a market cap of $2.44M USD, ranking #46725 globally and #6498 in China. It ranks #4134 in the Healthcare sector, and #493 in the Medical Care Facilities industry.

Global Rank

46725

Country Rank

6498

Sector Rank

4134

Industry Rank

493

Key Stats

Market Cap

$2.44MUSD

Revenue (TTM)

$3.33MUSD

Net Income (TTM)

$1.83MUSD

Profit Margin

55%

PE Ratio

0.0

PS Ratio

0.7

PB Ratio

-26.4

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Medical Care Facilities

CEO

Carlzo Cardwell open_in_new

Website

stemcellauthority.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	-99%	-99%	100%	0%	100%	-96%	-97%	-100%

News

Markets

Exchange	Ticker	Price	Quotes
OTC Markets (OTCMKTS / OTC) MIC: OTCM PRIMARY	SCAL Stem Cell Authority Ltd ISIN: US85857C1080 Shares Out.: Shares Outstanding: 12.18B¹ TV: TradingView: OTC: SCAL SA: Stock Analysis: OTC: SCAL YF: Yahoo Finance: SCAL GF: Google Finance: OTCMKTS: SCAL BA: Barron's: SCAL MS: Morningstar: PINX: SCAL	0.0002 USD	TV: TradingView: OTC: SCAL SA: Stock Analysis: OTC: SCAL YF: Yahoo Finance: SCAL GF: Google Finance: OTCMKTS: SCAL BA: Barron's: SCAL MS: Morningstar: PINX: SCAL

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Stem Cell Authority, Ltd.

Stem Cell Authority, Ltd., a technology development company, focuses on the collection and cryogenic preservation of stem cells. It specializes in the collection and cryogenic preservation of the hematopoietic stem cells from the umbilical cord blood; and the Miracle Mesenchymal stem cells from the Wharton’s jelly inside the umbilical cord of a newborn child. The company’s technology enables birthing professionals with a stem cell preservation program to serve their maternity patients in the United States. Stem Cell Authority, Ltd. is based in Fairlawn, Ohio.

Similar Companies

Industry: Medical Care Facilities (China)

Name	Market Cap (USD) diff.	PE	Country
Aier Eye Hospital Group Co., Ltd. SHE: 300015	$15.03B 101.77B CNY 617K%	30.1	China
Meinian Onehealth Healthcare Holdings Co., Ltd. SHE: 002044	$3.02B 20.46B CNY 124K%	75.1	China
Ping An Healthcare and Technology Company Ltd. SHEK: 1833	$2.94B 23.07B HKD 121K%	54.2	China
Topchoice Medical Co., Inc. SSE: 600763	$2.86B 19.35B CNY 117K%	38.6	China
Sanbo Hospital Management Group Ltd. SHE: 301293	$1.92B 12.97B CNY 79K%	218.8	China
Guangzhou Kingmed Diagnostics Group Co., Ltd. SSE: 603882	$1.87B 12.65B CNY 77K%	-	China

Industry: Medical Care Facilities (Global)

Name	Market Cap (USD) diff.	PE	Country
International Holding Company PJSC ADX: IHC	$232.18B 852.82B AED 10M%	44.1	United Arab Emirates
HCA Healthcare, Inc. NYSE: HCA	$96.73B 4M%	14.9	United States
Fresenius SE & Co. KGaA XETRA: FRE	$26.68B 22.97B EUR 1M%	15.0	Germany
Koninklijke Philips N.V. AMS: PHIA	$25.58B 22.02B EUR 1M%	24.9	Netherlands
Dr. Sulaiman Al Habib Medical Services Group Co. TADAWUL: 4013	$22.48B 84.42B SAR 923K%	35.2	Saudi Arabia
Labcorp Holdings Inc. NYSE: LH	$21.13B 867K%	24.6	United States

chevron_leftBack